ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,543Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 1942

$419K Total Retail Price of All Prescriptions

Rank: 191 out of 1942

383 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 710 604 1 1
METOPROLOL TARTRATE 458 425 2 9
LISINOPRIL 392 356 3 2
OMEPRAZOLE 358 326 4 4
WARFARIN SODIUM 348 330 5 11
FUROSEMIDE 315 305 6 5
LEVOTHYROXINE SODIUM 302 281 7 3
TRAMADOL HCL 272 260 8 19
AMLODIPINE BESYLATE 243 243 9 6
SERTRALINE HCL 203 160 10 20
LOSARTAN POTASSIUM 193 191 11 18
FENOFIBRATE 169 140 12 82
ATENOLOL 154 140 13 7
ALLOPURINOL 146 146 14 26
CITALOPRAM HBR 144 107 15 15
POTASSIUM CHLORIDE 142 138 16 17
METFORMIN HCL 139 106 17 10
HYDROCHLOROTHIAZIDE 132 122 18 8
METOPROLOL SUCCINATE 131 127 19 13
DIGOXIN 128 128 20 40
GABAPENTIN 123 109 21 16
POLYETHYLENE GLYCOL 3350 122 103 22 28
ISOSORBIDE MONONITRATE ER 114 107 23 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 113 24 22
METFORMIN HCL ER 113 101 24 46
ATORVASTATIN CALCIUM 110 98 26 14
DONEPEZIL HCL 106 95 27 30
HYDROCODONE-ACETAMINOPHEN 98 95 S3 28 12
TAMSULOSIN HCL 96 80 29 29
ALENDRONATE SODIUM 92 92 30 21
LOSARTAN-HYDROCHLOROTHIAZIDE 88 88 31 67
CARBIDOPA-LEVODOPA 87 87 32 64
ADVAIR DISKUS 82 52 33 35
NAMENDA 80 69 34 51
FLUDROCORTISONE ACETATE 77 77 35 256
TRAZODONE HCL 75 63 36 24
ATENOLOL-CHLORTHALIDONE 75 71 36 115
DOXAZOSIN MESYLATE 75 75 36 72
MIRTAZAPINE 72 60 39 38
FLUOXETINE HCL 71 70 40 45
PREDNISONE 70 68 41 27
DOXYCYCLINE HYCLATE 64 57 42 141
PROAIR HFA 62 47 43 41
ZETIA 62 49 43 75
LANTUS 59 59 45 49
FLUTICASONE PROPIONATE 57 46 46 37
VENLAFAXINE HCL ER 54 54 47 70
CHLORTHALIDONE 53 53 48 76
FINASTERIDE 51 44 49 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.